CHICAGO -- First-line treatment with encorafenib (Braftovi) and cetuximab (Erbitux) plus chemotherapy significantly improved ...

Cetuximab, an IgG1 chimeric monoclonal antibody against epidermal growth factor receptor (EGFR), has activity against colorectal cancers that express EGFR. From December 2003 to August 2005 ...

Adagrasib, an oral small-molecule inhibitor of mutant KRAS G12C protein, has shown clinical activity in pretreated patients with several tumor types, including colorectal cancer. Preclinical ...

Cetuximab has clearly increased the therapeutic armamentarium for the treatment of patients with mCRC. Studies looking at clinical, biochemical, and molecular markers for increased activity have ...

November 16, 2009 — Cetuximab (Erbitux) plus radiotherapy should be considered a standard option in the treatment of locoregionally advanced squamous cell carcinoma of the head and neck ...

Cetuximab combined with chemotherapy significantly improves PFS and OS in mCRC patients, as confirmed by a meta-analysis of 25 studies. The study highlights cetuximab's efficacy, despite ...

The efficacy and toxicity of cetuximab with concomitant platinum-based chemoradio- or chemotherapy in patients with locally advanced or metastatic ACC, respectively, was evaluated. Adenoid cystic ...

Encorafenib and cetuximab are types of targeted cancer drugs. Encorafenib is also known as Braftovi. Cetuximab is also known as Erbitux. You pronounce encorafenib as en-ko-raf-e-nib. And cetuximab is ...

Natural Killer Cell Consolidation for Acute Myelogenous Leukemia: A Cell Therapy Ready for Prime Time? The addition of cetuximab to TC did not significantly improve the primary end point, PFS-IRRC.

A study found that cetuximab along or with chemotherapy was an effective option in patients with metastatic colorectal cancer (CRC). Patients with metastatic colorectal cancer (mCRC) could be ...

Cetuximab is a monoclonal antibody that is used to treat several cancers including bowel cancer and head and neck cancer. Also called colorectal cancer, bowel cancer affects the colon and rectum ...